Goldman Sachs Group Inc Athersys, Inc Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$0.18 - $0.86 $40,123 - $191,700	222,907 New	222,907 $57,000
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.86 $9,628 - $46,002	53,491 Added 31.57%	222,907 $57,000
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $65,441 - $115,613	-109,069 Reduced 39.17%	169,416 $102,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $63,687 - $104,897	74,927 Added 36.81%	278,485 $251,000
Q3 2021 Nov 10, 2021	BUY	$1.33 - $1.77 $270,732 - $360,297	203,558 New	203,558 $271,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.